Page last updated: 2024-10-24

candesartan cilexetil and Oligohydramnios

candesartan cilexetil has been researched along with Oligohydramnios in 1 studies

candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects

Oligohydramnios: A condition of abnormally low AMNIOTIC FLUID volume. Principal causes include malformations of fetal URINARY TRACT; FETAL GROWTH RETARDATION; GESTATIONAL HYPERTENSION; nicotine poisoning; and PROLONGED PREGNANCY.

Research Excerpts

ExcerptRelevanceReference
"The pregnancy was terminated, and she delivered at 27 weeks' gestation."1.35Oligohydramnios and pulmonary hypoplasia: a case in which involvement of an angiotensin II receptor antagonist was suspected. ( Hirahara, F; Ishikawa, H; Kato, K; Okuda, M; Takahashi, T, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kato, K1
Okuda, M1
Ishikawa, H1
Takahashi, T1
Hirahara, F1

Other Studies

1 other study available for candesartan cilexetil and Oligohydramnios

ArticleYear
Oligohydramnios and pulmonary hypoplasia: a case in which involvement of an angiotensin II receptor antagonist was suspected.
    The journal of obstetrics and gynaecology research, 2008, Volume: 34, Issue:2

    Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Diabetic Nephrop

2008